News

PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival

October 7, 2019

(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr. Robert Coleman found an innovative combination therapy to significantly increase progression-free survival (PFS). In this phase III clinical trial, patients with previously untreated advanced-stage ovarian cancer received veliparib administered simultaneously with … Continued

Research

OCRA-Funded Research Elucidates New Immunotherapy Approach

September 19, 2019

(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach. In order to enable ovarian cancer patients to benefit from immunotherapy, Dr. Michael Goldberg’s research sought to understand how standard-of-care chemotherapy influences immune cells around the … Continued

OCRA News

Ovarian Cancer Quiz: Test Your Ovarian Cancer Knowledge

September 11, 2019

It’s important for everyone to know the symptoms and risk factors for ovarian cancer. If you or someone you know are experiencing any of the symptoms listed below, take notice and take it seriously—and also know that their presence does not automatically indicate ovarian cancer. Take our ovarian cancer quiz: Want to deepen your understanding … Continued

Community

OCRA-Funded Research Points to Surrounding Tissues for Further Study

September 10, 2019

(September 10, 2019) Ovarian clear-cell carcinoma is an aggressive form of ovarian cancer.  Endometriosis is derived from the uterine endometrium and is a known risk factor for ovarian clear-cell carcinoma.  Evidence supports ovarian clear-cell origins in the uterine endometrium.   It has been known for years that co-occurring cellular mutations are observed in ovarian clear-cell carcinoma, … Continued

OCRA News

OCRA-Funded Research Moves Immunotherapy Forward

September 5, 2019

(September 5, 2019) OCRA funded investigator Dmitriy Zamarin, MD, PhD contributed to a study that provides an intriguing hypothesis that mutation in genes like SMARCA4 may improve tumor recognition by the immune system. The body’s immune system plays a major role in controlling tumor growth. Specialized immune cells called T-cells identify cancer cells as “foreign” … Continued

OCRA News

September is Ovarian Cancer Awareness Month

August 26, 2019

Every September, we come together to shine a spotlight on ovarian cancer, spread awareness, and raise critical funds for research and patient support. How you can help during Ovarian Cancer Awareness Month: Give to ovarian cancer research and support Your support has a direct impact in funding new research and programs that support survivors and … Continued

Community

Should You Be Tested for BRCA Mutations? New Guidelines

August 22, 2019

(August 22, 2019) This week, The US Preventive Services Task Force published new recommendations on risk assessment, genetic counseling, and genetic testing for BRCA mutations and BRCA-related cancers. The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases … Continued

Research

New Direction for Research: Microbiota

August 21, 2019

(August 20, 2019) A new direction for research in ovarian cancer was brought to light last month thanks to a study published in Lancet Oncology. Researchers led by Dr. Nuno R. Nené of the University College London are investigating the role of microbiota in an individual’s risk of developing cancer. “The application of vaginal suppositories … Continued

Research

BE LOUD Video Series Turns Up the Volume on Ovarian Cancer

August 21, 2019

(August 21, 2019) Every 23 minutes, another woman in the U.S. hears the words “You have ovarian cancer” for the first time. Because ovarian cancer symptoms can be subtle and attributed to other factors, diagnosis often comes as a surprise. And along with it comes a host of overwhelming information, decisions to be made, and … Continued

Community

OCRA Funded Research Reveals New Drug Therapy Combination

July 26, 2019

(July 26, 2019) OCRA grantee Michael Yaffe, MD, PhD, led a study published earlier this month in Cell Systems which found success targeting cancer cells by combining two existing classes of drugs. Dr. Yaffe and colleagues found that this combination, which targets the cancer cells’ ability to divide, dramatically increases the drug’s capacity to kill … Continued

OCRA News

Watch OCRA’s 2019 National Conference Presentations on Live Stream

July 12, 2019

Couldn’t make it to our National Conference? Watch our expert presentations LIVE! For the first time, we live streamed all general sessions, so you can watch as our expert speakers present the latest ovarian cancer updates, from wherever you are. These broadcasts will remain available for viewing for a limited period of time following the original … Continued

Events

An Interview With President & CEO Audra Moran

June 19, 2019

(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to go through it alone. OCRA’s Woman to Woman program matches gynecologic cancer patients with trained survivor volunteers to provide support and mentoring to women when … Continued

OCRA News